{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:01Z","timestamp":1791907201704,"version":"4.3.4"},"reference-count":60,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Therapeutics"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Hyperhomocysteinemia (\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy) impairs nitric oxide endothelium\u2010dependent vasodilation, consequently leading to atherosclerosis, a risk factor for cardiovascular disease. Novel treatments for\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy are necessary.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      We tested the hypothesis that alamandine, a vasoactive peptide of the renin\u2010angiotensin system (\n                      <jats:styled-content style=\"fixed-case\">RAS<\/jats:styled-content>\n                      ), could reverse\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy\u2010induced vascular dysfunction through the MrgD receptor and that this is mediated by the protein kinase A (\n                      <jats:styled-content style=\"fixed-case\">PKA<\/jats:styled-content>\n                      ) pathway. Furthermore, we sought to determine a putative binding model of alamandine to the MrgD receptor through docking and molecular dynamics simulations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      The abdominal aorta was excised from New Zealand white rabbits (n\u00a0=\u00a015) and incubated with 3 mmol\/L Hcy (to mimic\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy) to induce vascular dysfunction in vitro. Vascular function was assessed by vasodilatory responses to cumulative doses of acetylcholine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Vasodilation was significantly impaired in\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy\u2010incubated aortic rings while alamandine reversed this effect (control, 74.2\u00a0\u00b1\u00a05.0%; Hcy, 30.3\u00a0\u00b1\u00a09.8%; alamandine\u00a0+\u00a0Hcy, 59.7\u00a0\u00b1\u00a04.8%,\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      .0001).\n                      <jats:styled-content style=\"fixed-case\">KT<\/jats:styled-content>\n                      5720 (\n                      <jats:styled-content style=\"fixed-case\">PKA<\/jats:styled-content>\n                      inhibitor) significantly inhibited the ability of alamandine to attenuate the impaired vasodilation caused by\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy (\n                      <jats:styled-content style=\"fixed-case\">KT<\/jats:styled-content>\n                      5720\u00a0+\u00a0Hcy\u00a0+\u00a0alamandine, 27.1\u00a0\u00b1\u00a024.1,\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      .01). Following immunohistochemistry analysis, the MrgD receptor was highly expressed within the media and endothelial layer of aortic rings in\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy compared to control (media: 0.23\u00a0\u00b1\u00a00.003 vs control 0.16\u00a0\u00b1\u00a00.01,\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      .05 and endothelium: 0.68\u00a0\u00b1\u00a00.07 vs control 0.13\u00a0\u00b1\u00a00.02,\n                      <jats:italic>P\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      .01, in\n                      <jats:styled-content style=\"fixed-case\">PA<\/jats:styled-content>\n                      \/I (A.U) units). Computational studies also propose certain interactions of alamandine within the MrgD transmembrane domain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study shows that alamandine is effective in reversing\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy\u2010induced vascular dysfunction, possibly through the\n                      <jats:styled-content style=\"fixed-case\">PKA<\/jats:styled-content>\n                      signaling pathway via MrgD. Our results indicate a therapeutic potential of alamandine in reversing the detrimental effects of\n                      <jats:styled-content style=\"fixed-case\">HH<\/jats:styled-content>\n                      cy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1755-5922.12306","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T07:23:04Z","timestamp":1505287384000},"source":"Crossref","is-referenced-by-count":38,"title":["Alamandine reverses hyperhomocysteinemia\u2010induced vascular dysfunction via\n                    <scp>PKA<\/scp>\n                    \u2010dependent mechanisms"],"prefix":"10.1111","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2904-5483","authenticated-orcid":false,"given":"Tawar","family":"Qaradakhi","sequence":"first","affiliation":[{"name":"Centre for Chronic Disease, College of Health and Biomedicine Victoria University  Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minos Timotheos","family":"Matsoukas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Patras  Patras Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hayes","sequence":"additional","affiliation":[{"name":"Centre for Chronic Disease, College of Health and Biomedicine Victoria University  Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rybalka","sequence":"additional","affiliation":[{"name":"Centre for Chronic Disease, College of Health and Biomedicine Victoria University  Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Caprnda","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Faculty of Medicine Comenius University  Bratislava Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kvetoslava","family":"Rimarova","sequence":"additional","affiliation":[{"name":"Department of Public Health and Hygiene, Faculty of Medicine Pavol Jozef Safarik University  Kosice Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Sepsi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Cardiology University Hospital  Brno Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"B\u00fcsselberg","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar Qatar Foundation \u2013 Education City  Doha Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kruzliak","sequence":"additional","affiliation":[{"name":"Department of Chemical Drugs, Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences  Brno Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Matsoukas","sequence":"additional","affiliation":[{"name":"ELdrug SA, Patras Science Park Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasso","family":"Apostolopoulos","sequence":"additional","affiliation":[{"name":"Centre for Chronic Disease, College of Health and Biomedicine Victoria University  Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Zulli","sequence":"additional","affiliation":[{"name":"Centre for Chronic Disease, College of Health and Biomedicine Victoria University  Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.155"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.529503"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0496-386"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707243370403"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.2.422"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00115-7"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340209788166940"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.53.5.557"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/327524a0"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00455.2011"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.112.270520"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151119487"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/iep.12087"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301077"},{"key":"e_1_2_7_16_1","first-page":"741","article-title":"Embryonic stem cells markers are present within rabbit atherosclerotic plaques","volume":"23","author":"Zulli A","year":"2008","journal-title":"Histol Histopathol"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12427"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-010-0557-7"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2012.01.004"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/pat.32.4.262.273"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3320213"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.2147if"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.062398"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145413"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-5-111"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.9.8.7768349"},{"key":"e_1_2_7_27_1","first-page":"705","article-title":"Simvastatin reduces endothelial NOS: caveolin\u20101 ratio but not the phosphorylation status of eNOS in vivo","volume":"19","author":"Arora R","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.29.1.291"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp033"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1110\/ps.062416606"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci4003014"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci400400m"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/prot.22711"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/ct200491c"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.540130805"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753944715597623"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000253889.09765.5f"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000189559.87328.e4"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.4.1620"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr304"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1139\/Y07-112"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.098514"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11558"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.4.1141"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.442053"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10361"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799040529"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2011.171"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1556\/APhysiol.101.2014.4.6"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2006.02.004"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmq102"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100122200"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.002907"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2009.00668.x"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2010.01.007"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M314240200"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/288373a0"}],"container-title":["Cardiovascular Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1755-5922.12306","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1755-5922.12306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T03:01:42Z","timestamp":1695697302000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1755-5922.12306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1111\/1755-5922.12306"],"URL":"https:\/\/doi.org\/10.1111\/1755-5922.12306","archive":["Portico"],"relation":{},"ISSN":["1755-5914","1755-5922"],"issn-type":[{"value":"1755-5914","type":"print"},{"value":"1755-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"article-number":"e12306"}}